WO2025214074A1 - Artificial valve anchoring device and assembly, and transcatheter heart valve replacement system - Google Patents
Artificial valve anchoring device and assembly, and transcatheter heart valve replacement systemInfo
- Publication number
- WO2025214074A1 WO2025214074A1 PCT/CN2025/082623 CN2025082623W WO2025214074A1 WO 2025214074 A1 WO2025214074 A1 WO 2025214074A1 CN 2025082623 W CN2025082623 W CN 2025082623W WO 2025214074 A1 WO2025214074 A1 WO 2025214074A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- artificial valve
- anchoring device
- valve
- artificial
- main body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
Definitions
- the present invention relates to the field of medical devices for cardiac surgery, and in particular to an artificial valve anchoring device, components and a transcatheter heart valve replacement system.
- Transcatheter valve replacement also known as percutaneous valve replacement (TAVR) is an interventional treatment for heart valve stenosis or decompensation. Compared with traditional open surgery, transcatheter valve replacement is inserted into the body through a catheter through blood vessels, without the need for open chest surgery, reducing surgical trauma and recovery time.
- TAVR percutaneous valve replacement
- the artificial valve may block the aortic outflow tract due to its low placement
- the present invention discloses an artificial valve anchoring device, an assembly and a transcatheter heart valve replacement system, aiming to solve the technical problems existing in the prior art.
- an embodiment of the present invention provides an artificial valve anchoring device, comprising a skirt portion, a main body portion, and a connecting portion, which are arranged in sequence from a blood inflow end to a blood outflow end;
- the skirt portion is radially extended outward, and the small diameter end of the skirt portion is connected to the main body portion;
- the main body portion includes a plurality of interconnected polygonal mesh structures capable of radially collapsing and expanding between a radially collapsed configuration and a radially expanded configuration;
- the connecting portion comprises a connecting arm, which is folded from the blood outflow end to the blood inflow end and extends radially outwardly.
- the connecting arm is used to connect or abut with the fishing ring.
- the connecting portion is provided with two connecting arms, and the two connecting arms are centrally symmetrically arranged or asymmetrically arranged.
- the distribution positions of the two connecting arms match the gaps in the junction area of the native leaflets, so that the connecting arms can penetrate into the gaps in the junction area of the native leaflets.
- the connecting arm has a connecting end and a free end; the connecting end is provided with an arc chamfer, and the inner diameter of the arc chamfer is not less than the coil cross-sectional diameter of the fishing ring; the free end is used to penetrate the coil gap of the fishing ring or abut against the bottom of the fishing ring.
- the free end extends straight outward and obliquely, or the free end deflects clockwise or counterclockwise from the connecting end and extends outward and obliquely.
- the included angle between the free end and the main body is ⁇ 1, 30° ⁇ 1 ⁇ 90°.
- a standard circular channel is defined in the middle of the main body.
- the axial length of the main body is smaller than the axial length of the native valve leaflet.
- the main body includes a shape memory material and can self-expand after being released in the heart.
- the diameter of the large-diameter end of the skirt portion is larger than the diameter of the valve orifice.
- an embodiment of the present invention provides an artificial valve anchoring assembly, comprising the artificial valve anchoring device as described in any one of the above items, and further comprising a fishing ring;
- the fishing ring is spiral-shaped and can be coiled outside the chordae tendineae plexus and connected to or abutted against the artificial valve anchoring device.
- the fishing ring is provided with an atrial segment and a functional segment in sequence;
- the atrial segment can be covered by the skirt portion of the prosthetic valve anchoring device
- the functional segment includes several turns of coils positioned at the native valve annulus, which are used to cooperate with the main body of the artificial valve anchoring device.
- the gaps in the coils allow the connecting arms of the artificial valve anchoring device to penetrate and connect with them, or the coils at the bottom of the functional segment abut against the connecting arms of the artificial valve anchoring device.
- an embodiment of the present invention provides a transcatheter heart valve replacement system, comprising the artificial valve anchoring assembly as described above, and an artificial valve; the artificial valve is interference-fitted with the main body of the artificial valve anchoring device.
- the artificial valve is configured as a self-expanding valve or a balloon-expandable valve.
- the present invention provides an artificial valve anchoring device, which can form an artificial valve anchoring assembly together with a fishing ring; when performing transcatheter heart valve replacement, the fishing ring and the artificial valve anchoring device are first implanted in sequence, because the inflow end of the artificial valve anchoring device has a skirt portion, the skirt portion can completely cover and fit tightly against the valve orifice of the mitral valve/tricuspid valve, so that the problems of paravalvular leakage and regurgitation can be solved before the artificial valve is released; the artificial valve anchoring device also has two connecting arms, which can penetrate into the gap in the junction area of the native valve leaflets and connect with the fishing ring, and the axial length of the main body of the artificial valve anchoring device is 1.5mm.
- the main body of the artificial valve anchoring device can work together with the capture ring to simplify the patient's complex mitral valve/tricuspid valve structure into a standard circular channel, providing a stable anchoring channel for the subsequent artificial valve.
- the main body and the artificial valve are connected by interference fit, and because the main body has a certain height, the release height of the artificial valve can be adjusted according to the actual situation of the patient when the artificial valve is subsequently implanted. On the one hand, it can avoid obstruction to the outflow tract to the greatest extent, and on the other hand, it also reduces the difficulty of operating the artificial valve during release.
- Another embodiment of the present invention further provides a transcatheter heart valve replacement system, including an artificial valve and the above-mentioned artificial valve anchoring assembly.
- a capture ring, an artificial valve anchoring device and an artificial valve are implanted in sequence.
- the capture ring and the artificial valve anchoring device in the present invention are implanted twice, which can effectively reduce the profile value of the delivery device, reduce the difficulty of delivery, and reduce damage to the patient's blood vessels; the artificial valve can be a balloon-expandable valve.
- the delivery system is simpler, the profile value is smaller, the accuracy requirement of the release position is low, and the operation difficulty is lower; compared with a self-expanding valve with leaflets, the difficulty of implanting an artificial valve anchoring device is lower, the length of the artificial valve anchoring device is shorter, the profile value of the delivery system is smaller, and the structure of the delivery system is simpler.
- FIG1 is a schematic structural diagram of a fishing ring in an embodiment disclosed in Example 1 of the present invention.
- FIG2 is a top view of a fishing ring according to an embodiment of the present invention disclosed in Example 1;
- FIG3 is a schematic structural diagram of an artificial valve anchoring device and a fishing ring in a coordinated state in an embodiment disclosed in Example 1 of the present invention
- FIG4 is a structural schematic diagram of an artificial valve anchoring device and a fishing ring in a mating state at another angle according to an embodiment of the present invention disclosed in Example 1;
- FIG5 is a top view of an artificial valve anchoring device and a fishing ring in a mating state according to an embodiment of the present invention disclosed in Example 1;
- FIG6 is a schematic structural diagram of an artificial valve anchoring device according to an embodiment of the present invention disclosed in Example 1;
- FIG7 is a top view of an artificial valve anchoring device according to an embodiment of the present invention disclosed in Example 1;
- FIG8 is a schematic diagram of the coordination between the main body and the artificial valve according to an embodiment of the present invention disclosed in Example 1;
- FIG9 is a schematic diagram of the cooperation between the main body and the artificial valve in another embodiment disclosed in Example 1 of the present invention.
- FIG10 is a schematic diagram of a fishing ring in an artificial valve anchoring assembly during implantation according to an embodiment of the present invention disclosed in Example 2;
- FIG11 is a schematic diagram of an artificial valve anchoring device in an artificial valve anchoring assembly during implantation according to an embodiment of the present invention disclosed in Example 2;
- FIG12 is a schematic diagram of an artificial valve in a transcatheter heart valve replacement system during implantation according to an embodiment of the present invention disclosed in Example 3;
- FIG13 is a schematic structural diagram of an artificial valve in an embodiment disclosed in Example 3 of the present invention.
- FIG14 is a schematic structural diagram of a transcatheter heart valve replacement system according to an embodiment of the present invention disclosed in Example 3;
- FIG15 is a schematic diagram of the release of an artificial valve in other positions of the transcatheter heart valve replacement system according to an embodiment of the present invention disclosed in Example 3;
- FIG16 is a schematic diagram showing the release of an artificial valve at other positions of a transcatheter heart valve replacement system in another embodiment disclosed in Example 3 of the present invention.
- Artificial valve anchoring device 10 skirt portion 11, main body portion 12, connecting arm 13, connecting end 131, free end 132, capturing ring 20, atrial segment 21, functional segment 22, artificial valve 30, and native valve leaflet 40.
- the terms “installed”, “connected”, and “connected” should be understood in a broad sense.
- it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or an indirect connection through an intermediate medium, or it can be internal communication between two components.
- the specific meanings of the above terms in the present invention can be understood according to the specific circumstances.
- the terms “first”, “second”, etc. are only used to distinguish the description and cannot be understood as indicating or implying relative importance.
- An embodiment of the present invention provides a prosthetic valve anchoring device 10 suitable for use within the mitral or tricuspid valve, preferably used in conjunction with a fishing ring 20 to address the problems existing in the prior art.
- the prosthetic valve anchoring device 10 has one end as the blood inflow end, corresponding to the atrial side, and the other end as the blood outflow end. From the blood inflow end to the blood outflow end, the device is sequentially provided with a skirt portion 11, a main body portion 12, and a connecting portion.
- the artificial valve anchoring device 10 in this embodiment needs to be released after the capture ring 20 is implanted, for the sake of convenience, the structure of the capture ring 20 will be partially described in this embodiment, but those skilled in the art should understand that the artificial valve anchoring device 10 is an independent device, and its structural composition does not include the capture ring 20 itself.
- the capture ring 20 includes a spiral coil that can be coiled around the chordae tendineae of the mitral valve/tricuspid valve after release, and position the artificial heart valve stent implanted in the mitral valve/tricuspid valve; in some embodiments, the capture ring 20 includes an atrial segment 21 and a functional segment 22, wherein the atrial segment 21 is positioned in the atrium and is configured to be curved roughly following the curvature of the atrial wall, and the functional segment 22 includes several turns of coils positioned at the native valve annulus for supporting the subsequently implanted artificial valve 30.
- the skirt portion 11 extends radially outward in a flange shape, and its small diameter end is connected to the main body 12;
- the main body 12 is composed of a number of interconnected polygonal grid structures, which can radially collapse during transportation and radially expand after release;
- the connecting portion is provided with a connecting arm 13, which is folded from the blood outflow end to the blood inflow end and extends radially outward at an angle, and the connecting arm 13 can be connected to or abutted against the fishing ring 20.
- the skirt portion 11 includes several diamond-shaped grid support members and elastic connectors. One end of the diamond-shaped grid support member is connected to the main body 12 by an elastic connector, and the other end can be releasably connected to the corresponding delivery device during delivery; the skirt portion 11 can expand in a flower-like manner after release, and the skirt portion 11 is preferably larger than the diameter of the valve orifice to ensure complete coverage of the valve orifice, thereby preventing paravalvular leakage; in some embodiments, the diameter of the large-diameter end of the skirt portion 11 is larger than the diameter of the atrial segment 21 of the capture ring 20, so that the skirt portion 11 can completely cover the atrial segment 21 of the capture ring 20, so as to further avoid regurgitation and possible paravalvular leakage at the valve annulus; after the connecting arm 13 is connected or abutted with the capture ring 20, the capture ring 20 will pull the artificial valve anchoring device 10 downward in the axial direction, so that the skirt portion 11 is further close to the valve orific
- the main body 12 includes one to several rows of polygonal grid structures, and adjacent grid structures are connected by wave rods or nodes with a certain degree of elasticity.
- the polygonal grid is preferably a rhombus, and pentagons, hexagons, etc. can also be selected to form closed-shaped units.
- the axial length of the main body 12 may be too long or too short, which may cause adverse effects. On the one hand, if the axial length of the main body 12 is too long, it may block the outflow tract or hinder the opening and closing of the leaflets. On the other hand, if the axial length of the main body 12 is too short, the artificial valve 30 may be deflected relative to the main body 12, making the two not coaxial, as shown in Figure 9, resulting in consequences such as loose sealing. Therefore, the axial length of the main body 12 should be less than the axial length of the native leaflets. Preferably, only one row of polygonal grids is provided.
- the axial length of the main body 12 is preferably 3-8 mm, which can ensure that the main body 12 will not affect the physiological function of the native valve tissue, and can also ensure that the artificial valve 30 is coaxial with the main body 12, avoiding unexpected deflection of the artificial valve 30, as shown in Figure 8.
- the main body 12 has a cylindrical structure, the outer side of which is adapted to the functional segment 22 of the capture ring 20, and the inner side is adapted to the artificial valve 30.
- a standard circular channel is defined in the middle of the inner side of the main body 12.
- the inner diameter of the circular channel is larger than the outer diameter of the prosthetic valve 30, allowing for an interference fit between the two. This ensures that the prosthetic valve 30 is stably connected to the prosthetic valve anchoring device 10 after release, preventing displacement of the prosthetic valve 30 during the cardiac cycle. Furthermore, during surgery, the release height of the prosthetic valve 30 relative to the main body 12 can be flexibly adjusted based on the patient's outflow tract condition to minimize outflow tract obstruction and reduce the operational difficulty of releasing the prosthetic valve 30.
- the connecting portion when the artificial valve anchoring device 10 is suitable for the tricuspid valve, the connecting portion is preferably provided with three connecting arms 13; when the artificial valve anchoring device 10 is suitable for the mitral valve, the connecting portion is preferably provided with two connecting arms 13.
- the multiple connecting arms 13 can be distributed in a centrally symmetrical or asymmetrical manner. After the artificial valve anchoring device 10 is released, the connecting arms 13 extend radially outward and penetrate into the coil gap of the functional segment 22 of the capturing ring 20 to connect therewith, or, the connecting arms 13 extend outward from the bottom of the functional segment 22 and abut against it to support the entire capturing ring 20.
- the artificial valve anchoring device 10 is suitable for the mitral valve, and the connecting part has two connecting arms 13. Since the human mitral valve leaflets are not completely symmetrical, the distribution positions of the two connecting arms 13 are preferably matched with the gaps in the junction area of the native leaflets 40, so that the connecting arms 13 can pass through the gaps in the junction area of the native leaflets 40 and connect to the capturing ring 20. At this time, the presence of the connecting arms 13 will not block the opening and closing movement of the patient's native leaflets 40, thereby avoiding the patient losing mitral valve function during the operation, causing a large amount of regurgitation, and endangering life.
- the connecting arm 13 has a connecting end 131 and a free end 132.
- the connecting end 131 has an arc-shaped chamfer, and the inner diameter of the arc-shaped chamfer is not less than the cross-sectional diameter of the coil of the fishing ring 20, so that when the connecting arm 13 is connected to the fishing ring 20, the coil can fall into the arc-shaped chamfer, thereby increasing the stability of the connection between the two;
- the free end 132 is used to penetrate the coil gap of the fishing ring 20, and the free end 132 is preferably configured as a rounded blunt structure to prevent damage to the native valve tissue.
- the angle between the free end 132 and the main body 12 is ⁇ 1, 30° ⁇ 1 ⁇ 90°, to ensure that after the artificial valve anchoring device 10 is released, the connecting arm 13 can smoothly penetrate between the adjacent coils of the functional segment 22 of the capture ring 20, or abut against the bottom coil of the functional segment 22, and the part of the connecting arm 13 radially exposed to the coil can extend upward at an angle to avoid affecting other surrounding tissue structures over a large area.
- the free end 132 of the connecting arm 13 is configured to extend straight outward at an angle.
- the connecting arm 13 can pass straight through the gap in the junction area of the patient's own valve leaflets 40 after being released, and further penetrate into the gap between adjacent coils, or abut against the bottom coil of the functional segment 22; in other embodiments, the free end 132 of the connecting arm 13 is deflected clockwise or counterclockwise from the connecting end 131 and extends outward at an angle.
- the deflected structure can further increase the contact area between the connecting arm 13 and the coil, thereby further increasing the friction force and ensuring the tightness of the combination of the two.
- the cross-sectional thickness of the connecting arm 13 is not less than the gap between adjacent coils of the functional segment 22 of the fishing ring 20, so as to ensure that the connecting arm 13 forms a stable interference connection with the coil after penetrating the coil gap, thereby increasing the friction between the two and preventing the two from separating; in other embodiments, the cross-sectional thickness of the connecting arm 13 is less than the gap between adjacent coils of the functional segment 22 of the fishing ring 20, so that the connecting arm 13 can pass through the gap of the coil more easily.
- the skirt portion 11 and the main body portion 12 are connected by welding, suturing, riveting or integral molding, and the connecting portion and the main body portion 12 are also connected by welding, suturing, riveting or integral molding.
- the three are preferably made of the same material and are in a cylindrical compressed state when transported in the blood vessels, and are opened by self-expansion or balloon expansion after reaching the heart.
- the artificial valve anchoring device 10 achieves radial expansion of its released configuration through a balloon.
- the entire device can be made of materials such as medical stainless steel and cobalt-chromium alloy.
- the artificial valve anchoring device 10 achieves radial expansion of its released configuration by self-expansion.
- the device is made of a shape memory material, preferably a nickel-titanium alloy memory material or other memory polymer materials or alloys.
- the artificial valve anchoring device 10 allows the doctor to flexibly adjust the release height of the artificial valve 30 according to the actual situation of the patient after implantation, thereby avoiding outflow tract obstruction to the greatest extent; and the artificial valve anchoring device 10 and the capture ring 20 work together to simplify the complex mitral valve structure into a circular channel, providing a stable anchoring point for the artificial valve 30, and can be suitable for most patients; because the artificial valve anchoring device 10 has a skirt portion 11, it can solve the problems of paravalvular leakage and regurgitation before the artificial valve 30 is released, and after the capture ring 20 and the artificial valve anchoring device 10 are implanted, it will not affect the normal function and movement of the patient's valve leaflets, thereby reducing the surgical risk.
- An embodiment of the present invention provides an artificial valve anchoring assembly, including a fishing ring 20 and the artificial valve anchoring device 10 described in the above embodiment 1.
- the technical features already included in the above embodiment 1 are naturally inherited in this embodiment and will not be repeated one by one.
- the capture ring 20 includes a core and a wrapping layer from the inside to the outside.
- the core is made of preformed memory metal, which can undergo elastic deformation in at least the radial and axial directions to adapt to the changes in the shape of the myocardial tissue.
- the wrapping layer is made of a polymer material and is used to provide friction.
- the capture ring 20 is also provided with a proximal connector and a developing ring. The proximal connector is used to be releasably connected to a conveying device that delivers the capture ring 20, and the developing ring is used to observe and determine the position of the capture ring 20 during the operation.
- the implantation process of the artificial valve 30 anchoring component is specifically as follows: first, the capture ring 20 is implanted through a transcatheter method, as shown in Figure 10. At this time, since the capture ring 20 crosses the patient's valve orifice, it may cause mitral valve insufficiency and regurgitation; next, the artificial valve anchoring device 10 is implanted through a transcatheter method, as shown in Figure 11.
- the connecting arm 13 is aligned with the gap in the junction area of the patient's own valve leaflets 40, and then the artificial valve anchoring device 10 is moved back and forth so that the connecting arm 13 can penetrate and hook the functional segment 22 of the capture ring 20, and then the skirt portion 11 covers the atrial segment 21 of the capture ring 20, and finally the artificial valve anchoring device 10 is released.
- the artificial valve anchoring device 10 fits tightly with the capturing ring 20, and the skirt portion 11 of the occluding frame covers the patient's valve ring, so abnormal phenomena such as regurgitation or paravalvular leakage will not occur.
- the connecting arm 13 is located in the gap at the junction of the patient's own valve leaflets 40. After the capturing ring 20 and the artificial valve anchoring device 10 are implanted, they will not hinder the opening and closing movement of the patient's own mitral valve leaflets, thereby avoiding the patient from losing mitral valve function during the operation and causing a large amount of regurgitation.
- An embodiment of the present invention provides a transcatheter heart valve replacement system, as shown in Figures 12 to 16.
- the system includes an artificial valve 30 and the artificial valve anchoring assembly described in the above-mentioned embodiment 2.
- the technical features already included in the above-mentioned embodiments 1 and 2 are naturally inherited in this embodiment and will not be repeated one by one.
- the artificial valve 30 is released after the artificial valve anchoring assembly is implanted, and the artificial valve 30 is interference fit with the main body 12 of the artificial valve anchoring device 10 .
- the artificial valve 30 is configured as a self-expanding valve or a balloon-expandable valve; when configured as a self-expanding valve, the valve stent of the artificial valve 30 is made of metal or polymer materials, such as nickel-titanium alloy memory material or other memory polymer materials or alloys, and the above materials are processed to form a number of interconnected polygonal grid structures, which can self-expand under the action of body temperature and restore their original properties after being released in the heart; when configured as a balloon-expandable valve, the valve stent of the artificial valve 30 is made of medical stainless steel and cobalt-chromium alloy and other materials, and is pre-processed by weaving, welding, riveting, threading, etc. to form a number of interconnected polygonal grid structures, and when released, the expansion of the artificial valve 30 is achieved by the force of the balloon expansion, and when the artificial valve 30 expands to the required extent, the balloon is withdrawn.
- the valve stent of the artificial valve 30 when
- the specific structure and operation mode of the artificial valve 30 can be selected from any embodiment disclosed in the prior art, and will not be specifically limited or elaborated herein.
- the operation process of the transcatheter heart valve replacement system is specifically as follows: first, the capture ring 20 and the artificial valve anchoring device 10 are released in sequence, and the specific operation process is shown in the above-mentioned embodiment 2. Then, the artificial valve 30 is implanted through a transcatheter method, and the artificial valve 30 is unfolded inside the artificial valve anchoring device 10, as shown in Figure 12. Since the outer diameter of the artificial valve 30 is larger than the inner diameter of the main body 12 of the artificial valve anchoring device 10, the two can achieve an interference fit, so that the artificial valve 30 can be stably anchored inside the artificial valve anchoring device 10.
- the release height of the artificial valve 30 can also be adjusted according to the patient's outflow tract condition, as shown in Figures 15 and 16, to minimize outflow tract obstruction. At this time, the artificial valve 30 is tightly fitted with the artificial valve anchoring device 10. Under the action of the skirt 11, the artificial valve 30 has no paravalvular leakage or regurgitation.
- the capture ring 20 and the artificial valve anchoring device 10 in this embodiment are implanted twice, which can effectively reduce the profile value of the delivery device, reduce the difficulty of delivery, and reduce damage to the patient's blood vessels; the artificial valve 30 selects a balloon-expandable valve.
- the delivery system is simpler, the profile value is smaller, the accuracy requirement of the release position is low, and the operation difficulty is lower; compared with the self-expanding valve with leaflets, the difficulty of implanting the artificial valve anchoring device 10 is lower, the length of the artificial valve anchoring device 10 is shorter, the profile value of the delivery system is smaller, and the structure of the delivery system is simpler.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
Abstract
Description
本发明涉及心脏术用医疗器械领域,尤其涉及一种人工瓣膜锚定装置、组件及经导管心脏瓣膜置换系统。The present invention relates to the field of medical devices for cardiac surgery, and in particular to an artificial valve anchoring device, components and a transcatheter heart valve replacement system.
经导管瓣膜置换术,也称为经皮瓣膜置换术(Transcatheter Valve Replacement,TAVR),是一种用于治疗心脏瓣膜狭窄或失代偿的介入性治疗方法,相比传统的开放性手术,经导管瓣膜置换术通过导管经血管插入体内,无需开胸,减少了手术创伤和康复时间。Transcatheter valve replacement, also known as percutaneous valve replacement (TAVR), is an interventional treatment for heart valve stenosis or decompensation. Compared with traditional open surgery, transcatheter valve replacement is inserted into the body through a catheter through blood vessels, without the need for open chest surgery, reducing surgical trauma and recovery time.
在施行经导管瓣膜置换术时,医生会利用导管引导人工瓣膜至患者的心脏位置,并将其定位在受损的瓣膜上,但经研究发现,现有的人工瓣膜在使用时存在诸多问题:During transcatheter valve replacement surgery, doctors use a catheter to guide the artificial valve to the patient's heart and position it on the damaged valve. However, studies have found that existing artificial valves have many problems when used:
(1)人工瓣膜由于放置的位置较低,可能阻挡主动脉的流出道;(1) The artificial valve may block the aortic outflow tract due to its low placement;
(2)目前在一些现有方案中提出,可以先在瓣环处放置一个“支撑架”,然后将瓣膜放置在“支撑架”中间,在手术过程中,“支撑架”会将瓣叶完全撑开,使得患者的瓣叶无法开合,瓣膜功能彻底失效,会因来不及植入人工瓣膜而危及患者生命;(2) Some existing plans currently propose placing a "support frame" at the valve annulus first, and then placing the valve in the middle of the "support frame". During the operation, the "support frame" will completely expand the valve leaflets, making it impossible for the patient's valve leaflets to open and close, and the valve function will completely fail. This will endanger the patient's life because there is no time to implant an artificial valve;
(3)人体的二尖瓣或三尖瓣的解剖结构复杂,不同患者的解剖结构差异很大,现有的人工瓣膜难以适应大多数患者的使用需求。(3) The anatomical structure of the human mitral valve or tricuspid valve is complex and varies greatly from patient to patient. Existing artificial valves are difficult to adapt to the needs of most patients.
本发明公开了一种人工瓣膜锚定装置、组件及经导管心脏瓣膜置换系统,旨在解决现有技术中存在的技术问题。The present invention discloses an artificial valve anchoring device, an assembly and a transcatheter heart valve replacement system, aiming to solve the technical problems existing in the prior art.
本发明采用下述技术方案:The present invention adopts the following technical solutions:
一方面,本发明实施例提供了一种人工瓣膜锚定装置,包括裙边部、主体部和连接部,三者自血液流入端至血液流出端依次设置;On the one hand, an embodiment of the present invention provides an artificial valve anchoring device, comprising a skirt portion, a main body portion, and a connecting portion, which are arranged in sequence from a blood inflow end to a blood outflow end;
裙边部径向向外延伸设置,裙边部的小直径端与主体部相连;The skirt portion is radially extended outward, and the small diameter end of the skirt portion is connected to the main body portion;
主体部包括若干相互连接的多边形网格结构,能够在径向塌缩构造与径向扩张构造之间径向塌缩和扩张;The main body portion includes a plurality of interconnected polygonal mesh structures capable of radially collapsing and expanding between a radially collapsed configuration and a radially expanded configuration;
连接部包括连接臂,连接臂由血液流出端向血液流入端翻折,并径向向外倾斜延伸,连接臂用于与捕捞环连接或抵接。The connecting portion comprises a connecting arm, which is folded from the blood outflow end to the blood inflow end and extends radially outwardly. The connecting arm is used to connect or abut with the fishing ring.
作为优选的技术方案,连接部设有两个连接臂,两个连接臂呈中心对称设置或非对称设置。As a preferred technical solution, the connecting portion is provided with two connecting arms, and the two connecting arms are centrally symmetrically arranged or asymmetrically arranged.
作为优选的技术方案,两个连接臂的分布位置与自体瓣叶交界区域的空隙相匹配,使得连接臂能够穿入至自体瓣叶交界区域的空隙中。As a preferred technical solution, the distribution positions of the two connecting arms match the gaps in the junction area of the native leaflets, so that the connecting arms can penetrate into the gaps in the junction area of the native leaflets.
作为优选的技术方案,连接臂具有连接端及自由端;连接端设有弧形倒角,弧形倒角的圆弧内径不小于捕捞环的线圈横截面直径;自由端用于穿入捕捞环的线圈间隙或抵接于所述捕捞环的底部。As a preferred technical solution, the connecting arm has a connecting end and a free end; the connecting end is provided with an arc chamfer, and the inner diameter of the arc chamfer is not less than the coil cross-sectional diameter of the fishing ring; the free end is used to penetrate the coil gap of the fishing ring or abut against the bottom of the fishing ring.
作为优选的技术方案,自由端向外径直倾斜延伸,或者,自由端自连接端顺时针或逆时针偏转并向外倾斜延伸。As a preferred technical solution, the free end extends straight outward and obliquely, or the free end deflects clockwise or counterclockwise from the connecting end and extends outward and obliquely.
作为优选的技术方案,自由端与主体部的夹角为α1,30°≤α1≤90°。As a preferred technical solution, the included angle between the free end and the main body is α1, 30°≤α1≤90°.
作为优选的技术方案,主体部的中部限定有一个标准的圆形通道。As a preferred technical solution, a standard circular channel is defined in the middle of the main body.
作为优选的技术方案,主体部的轴向长度小于自体瓣叶的轴向长度。As a preferred technical solution, the axial length of the main body is smaller than the axial length of the native valve leaflet.
作为优选的技术方案,主体部包括形状记忆材料,能够在心内释放后自膨胀。As a preferred technical solution, the main body includes a shape memory material and can self-expand after being released in the heart.
作为优选的技术方案,裙边部的大直径端的直径大于瓣口的直径。As a preferred technical solution, the diameter of the large-diameter end of the skirt portion is larger than the diameter of the valve orifice.
第二方面,本发明实施例提供了一种人工瓣膜锚定组件,包括如上任一项所述的人工瓣膜锚定装置,还包括捕捞环;In a second aspect, an embodiment of the present invention provides an artificial valve anchoring assembly, comprising the artificial valve anchoring device as described in any one of the above items, and further comprising a fishing ring;
捕捞环呈螺旋状,能够盘绕于腱索丛外,并与人工瓣膜锚定装置连接或抵接。The fishing ring is spiral-shaped and can be coiled outside the chordae tendineae plexus and connected to or abutted against the artificial valve anchoring device.
作为优选的技术方案,捕捞环依次设有心房段与功能段;As a preferred technical solution, the fishing ring is provided with an atrial segment and a functional segment in sequence;
心房段能够被人工瓣膜锚定装置的裙边部所覆盖;The atrial segment can be covered by the skirt portion of the prosthetic valve anchoring device;
功能段包括定位于原生瓣环处的数匝线圈,用于与人工瓣膜锚定装置的主体部相配合,线圈的间隙供人工瓣膜锚定装置的连接臂穿入,并与之连接,或者,位于功能段底部的线圈与人工瓣膜锚定装置的连接臂相抵接。The functional segment includes several turns of coils positioned at the native valve annulus, which are used to cooperate with the main body of the artificial valve anchoring device. The gaps in the coils allow the connecting arms of the artificial valve anchoring device to penetrate and connect with them, or the coils at the bottom of the functional segment abut against the connecting arms of the artificial valve anchoring device.
第三方面,本发明实施例提供了一种经导管心脏瓣膜置换系统,包括如上所述的人工瓣膜锚定组件,还包括人工瓣膜;人工瓣膜与人工瓣膜锚定装置的主体部过盈配合。In a third aspect, an embodiment of the present invention provides a transcatheter heart valve replacement system, comprising the artificial valve anchoring assembly as described above, and an artificial valve; the artificial valve is interference-fitted with the main body of the artificial valve anchoring device.
作为优选的技术方案,人工瓣膜被配置为自膨胀式瓣膜或球囊扩张式瓣膜。As a preferred technical solution, the artificial valve is configured as a self-expanding valve or a balloon-expandable valve.
本发明采用的技术方案能够达到以下有益效果:The technical solution adopted by the present invention can achieve the following beneficial effects:
本发明提供了一种人工瓣膜锚定装置,该人工瓣膜锚定装置可以与捕捞环一同组成人工瓣膜锚定组件;在进行经导管心脏瓣膜置换术时,首先依次植入捕捞环及人工瓣膜锚定装置,由于人工瓣膜锚定装置的流入端具有裙边部,裙边部能够完全覆盖并紧贴二尖瓣/三尖瓣的瓣口,因此可以在人工瓣膜释放之前即解决瓣周漏和反流的问题;人工瓣膜锚定装置还具有两个连接臂,连接臂能够穿入至自体瓣叶交界区域的空隙中,并与捕捞环连接,同时人工瓣膜锚定装置的主体部的轴向长度小于自体瓣叶的轴向长度,从而不会影响自体瓣叶的功能及运动;人工瓣膜锚定装置的主体部可以与捕捞环共同作用,将患者复杂的二尖瓣/三尖瓣结构简化成一个标准的圆形通道,为后续人工瓣膜提供一个稳定的锚定通道,主体部与人工瓣膜通过过盈配合实现二者的连接,且由于主体部具有一定高度,因此在后续植入人工瓣膜时,可以根据患者的实际情况,调整人工瓣膜的释放高度,一方面能够最大限度的避免对流出道造成阻挡,另一方面还降低了人工瓣膜在释放时的操作难度。The present invention provides an artificial valve anchoring device, which can form an artificial valve anchoring assembly together with a fishing ring; when performing transcatheter heart valve replacement, the fishing ring and the artificial valve anchoring device are first implanted in sequence, because the inflow end of the artificial valve anchoring device has a skirt portion, the skirt portion can completely cover and fit tightly against the valve orifice of the mitral valve/tricuspid valve, so that the problems of paravalvular leakage and regurgitation can be solved before the artificial valve is released; the artificial valve anchoring device also has two connecting arms, which can penetrate into the gap in the junction area of the native valve leaflets and connect with the fishing ring, and the axial length of the main body of the artificial valve anchoring device is 1.5mm. It is smaller than the axial length of the native leaflets, so as not to affect the function and movement of the native leaflets; the main body of the artificial valve anchoring device can work together with the capture ring to simplify the patient's complex mitral valve/tricuspid valve structure into a standard circular channel, providing a stable anchoring channel for the subsequent artificial valve. The main body and the artificial valve are connected by interference fit, and because the main body has a certain height, the release height of the artificial valve can be adjusted according to the actual situation of the patient when the artificial valve is subsequently implanted. On the one hand, it can avoid obstruction to the outflow tract to the greatest extent, and on the other hand, it also reduces the difficulty of operating the artificial valve during release.
本发明的另一实施例进一步提供了一种经导管心脏瓣膜置换系统,包括人工瓣膜及上述人工瓣膜锚定组件,在进行心脏瓣膜置换时,分别依次植入捕捞环、人工瓣膜锚定装置及人工瓣膜,相较于现有技术,本发明中的捕捞环与人工瓣膜锚定装置分两次植入,能够有效减小输送装置的profile值,降低输送难度,减小对患者血管的伤害;人工瓣膜可以选择球囊扩张式瓣膜,相较于带裙边的自膨胀式瓣膜,输送系统更为简单,profile值更小,释放位置的准确度要求低,操作难度更低;相较于带瓣叶的自膨胀式瓣膜,植入人工瓣膜锚定装置的难度更低,人工瓣膜锚定装置的长度更短,输送系统的profile值更小,输送系统的结构更简单。Another embodiment of the present invention further provides a transcatheter heart valve replacement system, including an artificial valve and the above-mentioned artificial valve anchoring assembly. When performing heart valve replacement, a capture ring, an artificial valve anchoring device and an artificial valve are implanted in sequence. Compared with the existing technology, the capture ring and the artificial valve anchoring device in the present invention are implanted twice, which can effectively reduce the profile value of the delivery device, reduce the difficulty of delivery, and reduce damage to the patient's blood vessels; the artificial valve can be a balloon-expandable valve. Compared with a self-expanding valve with a skirt, the delivery system is simpler, the profile value is smaller, the accuracy requirement of the release position is low, and the operation difficulty is lower; compared with a self-expanding valve with leaflets, the difficulty of implanting an artificial valve anchoring device is lower, the length of the artificial valve anchoring device is shorter, the profile value of the delivery system is smaller, and the structure of the delivery system is simpler.
为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述中所需要使用的附图作简单地介绍,构成本发明的一部分,本发明的示意性实施例及其说明解释本发明,并不构成对本发明的不当限定。在附图中:In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments, which constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are provided to explain the present invention and do not constitute an undue limitation of the present invention. In the drawings:
图1为本发明实施例1公开的一种实施方式中捕捞环的结构示意图;FIG1 is a schematic structural diagram of a fishing ring in an embodiment disclosed in Example 1 of the present invention;
图2为本发明实施例1公开的一种实施方式中捕捞环的俯视图;FIG2 is a top view of a fishing ring according to an embodiment of the present invention disclosed in Example 1;
图3为本发明实施例1公开的一种实施方式中人工瓣膜锚定装置与捕捞环在配合状态的结构示意图;FIG3 is a schematic structural diagram of an artificial valve anchoring device and a fishing ring in a coordinated state in an embodiment disclosed in Example 1 of the present invention;
图4为本发明实施例1公开的一种实施方式中人工瓣膜锚定装置与捕捞环在配合状态另一角度的结构示意图;FIG4 is a structural schematic diagram of an artificial valve anchoring device and a fishing ring in a mating state at another angle according to an embodiment of the present invention disclosed in Example 1;
图5为本发明实施例1公开的一种实施方式中人工瓣膜锚定装置与捕捞环在配合状态的俯视图;FIG5 is a top view of an artificial valve anchoring device and a fishing ring in a mating state according to an embodiment of the present invention disclosed in Example 1;
图6为本发明实施例1公开的一种实施方式中人工瓣膜锚定装置的结构示意图;FIG6 is a schematic structural diagram of an artificial valve anchoring device according to an embodiment of the present invention disclosed in Example 1;
图7为本发明实施例1公开的一种实施方式中人工瓣膜锚定装置的俯视图;FIG7 is a top view of an artificial valve anchoring device according to an embodiment of the present invention disclosed in Example 1;
图8为本发明实施例1公开的一种实施方式中主体部与人工瓣膜的配合示意图;FIG8 is a schematic diagram of the coordination between the main body and the artificial valve according to an embodiment of the present invention disclosed in Example 1;
图9为本发明实施例1公开的另一种实施方式中主体部与人工瓣膜的配合示意图;FIG9 is a schematic diagram of the cooperation between the main body and the artificial valve in another embodiment disclosed in Example 1 of the present invention;
图10为本发明实施例2公开的一种实施方式中人工瓣膜锚定组件中的捕捞环在植入时的示意图;FIG10 is a schematic diagram of a fishing ring in an artificial valve anchoring assembly during implantation according to an embodiment of the present invention disclosed in Example 2;
图11为本发明实施例2公开的一种实施方式中人工瓣膜锚定组件中的人工瓣膜锚定装置在植入时的示意图;FIG11 is a schematic diagram of an artificial valve anchoring device in an artificial valve anchoring assembly during implantation according to an embodiment of the present invention disclosed in Example 2;
图12为本发明实施例3公开的一种实施方式中经导管心脏瓣膜置换系统中的人工瓣膜在植入时的示意图;FIG12 is a schematic diagram of an artificial valve in a transcatheter heart valve replacement system during implantation according to an embodiment of the present invention disclosed in Example 3;
图13为本发明实施例3公开的一种实施方式中人工瓣膜的结构示意图;FIG13 is a schematic structural diagram of an artificial valve in an embodiment disclosed in Example 3 of the present invention;
图14为本发明实施例3公开的一种实施方式中经导管心脏瓣膜置换系统的结构示意图;FIG14 is a schematic structural diagram of a transcatheter heart valve replacement system according to an embodiment of the present invention disclosed in Example 3;
图15为本发明实施例3公开的一种实施方式中人工瓣膜在经导管心脏瓣膜置换系统其他位置时的释放示意图;FIG15 is a schematic diagram of the release of an artificial valve in other positions of the transcatheter heart valve replacement system according to an embodiment of the present invention disclosed in Example 3;
图16为本发明实施例3公开的另一种实施方式中人工瓣膜在经导管心脏瓣膜置换系统其他位置时的释放示意图。FIG16 is a schematic diagram showing the release of an artificial valve at other positions of a transcatheter heart valve replacement system in another embodiment disclosed in Example 3 of the present invention.
附图标记说明:Description of reference numerals:
人工瓣膜锚定装置10,裙边部11,主体部12,连接臂13,连接端131,自由端132,捕捞环20,心房段21,功能段22,人工瓣膜30,自体瓣叶40。Artificial valve anchoring device 10, skirt portion 11, main body portion 12, connecting arm 13, connecting end 131, free end 132, capturing ring 20, atrial segment 21, functional segment 22, artificial valve 30, and native valve leaflet 40.
为使本发明的目的、技术方案和优点更加清楚,下面将结合本发明具体实施例及相应的附图对本发明技术方案进行清楚、完整地描述。在本发明的描述中,需要说明的是,术语“或”通常是以包括“和/或”的含义而进行使用的,除非内容另外明确指出外。To make the objectives, technical solutions, and advantages of the present invention more clear, the technical solutions of the present invention will be clearly and completely described below in conjunction with specific embodiments of the present invention and corresponding drawings. In the description of the present invention, it should be noted that the term "or" is generally used in the sense of including "and/or" unless the content clearly indicates otherwise.
在本发明的描述中,需要说明的是,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。另外,在本申请的描述中,术语“第一”、“第二”等仅用于区分描述,而不能理解为指示或暗示相对重要性。In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or an indirect connection through an intermediate medium, or it can be internal communication between two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to the specific circumstances. In addition, in the description of this application, the terms "first", "second", etc. are only used to distinguish the description and cannot be understood as indicating or implying relative importance.
显然,所描述的实施例仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。Obviously, the embodiments described are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.
实施例1Example 1
本发明实施例提供了一种人工瓣膜锚定装置10,适用于二尖瓣或三尖瓣内,并优选与捕捞环20搭配使用,以解决现有技术中所存在的问题。参考图1—图9,人工瓣膜锚定装置10的一端为血液流入端,对应于心房侧,另一端为血液流出端,自血液流入端至血液流出端依次设有裙边部11、主体部12及连接部。An embodiment of the present invention provides a prosthetic valve anchoring device 10 suitable for use within the mitral or tricuspid valve, preferably used in conjunction with a fishing ring 20 to address the problems existing in the prior art. Referring to Figures 1-9 , the prosthetic valve anchoring device 10 has one end as the blood inflow end, corresponding to the atrial side, and the other end as the blood outflow end. From the blood inflow end to the blood outflow end, the device is sequentially provided with a skirt portion 11, a main body portion 12, and a connecting portion.
由于本实施例中的人工瓣膜锚定装置10需要在捕捞环20植入后再进行释放,为便于说明,本实施例中将对捕捞环20的结构进行部分说明,但本领域技术人员应理解,人工瓣膜锚定装置10是一个独立的装置,其结构组成并不包含捕捞环20本身。Since the artificial valve anchoring device 10 in this embodiment needs to be released after the capture ring 20 is implanted, for the sake of convenience, the structure of the capture ring 20 will be partially described in this embodiment, but those skilled in the art should understand that the artificial valve anchoring device 10 is an independent device, and its structural composition does not include the capture ring 20 itself.
如图1、图2,在一些实施例中,捕捞环20包括一个呈螺旋状的线圈,在释放后能够盘绕于二尖瓣/三尖瓣腱索丛,并定位被植入二尖瓣/三尖瓣内的人工心脏瓣膜支架;在一些实施例中,捕捞环20包括心房段21与功能段22,其中,心房段21定位于心房中,并被配置为大致遵循心房壁曲率的弯曲状,功能段22包括定位于原生瓣环处的数匝线圈,用于支撑后续植入的人工瓣膜30。As shown in Figures 1 and 2, in some embodiments, the capture ring 20 includes a spiral coil that can be coiled around the chordae tendineae of the mitral valve/tricuspid valve after release, and position the artificial heart valve stent implanted in the mitral valve/tricuspid valve; in some embodiments, the capture ring 20 includes an atrial segment 21 and a functional segment 22, wherein the atrial segment 21 is positioned in the atrium and is configured to be curved roughly following the curvature of the atrial wall, and the functional segment 22 includes several turns of coils positioned at the native valve annulus for supporting the subsequently implanted artificial valve 30.
如图3—图7,在一些实施例中,裙边部11呈法兰盘状径向向外延伸,其小直径端与主体部12相连;主体部12由若干相互连接的多边形网格结构组成,能够在输送时径向塌缩,在释放后径向扩张;连接部设有连接臂13,连接臂13自血液流出端向血液流入端翻折,并径向向外倾斜延伸,连接臂13能够与捕捞环20相连接或抵接。As shown in Figures 3 to 7, in some embodiments, the skirt portion 11 extends radially outward in a flange shape, and its small diameter end is connected to the main body 12; the main body 12 is composed of a number of interconnected polygonal grid structures, which can radially collapse during transportation and radially expand after release; the connecting portion is provided with a connecting arm 13, which is folded from the blood outflow end to the blood inflow end and extends radially outward at an angle, and the connecting arm 13 can be connected to or abutted against the fishing ring 20.
在一些实施例中,裙边部11包括数个菱形网格支撑件及弹性连接件,菱形网格支撑件的一端通过弹性连接件与主体部12相连,另一端可在输送时与相应的输送装置进行可释放式的连接;裙边部11在释放后可呈花朵样扩张,裙边部11优选大于瓣口的直径,以保证对瓣口进行完全覆盖,从而防止瓣周漏;在一些实施例中,裙边部11的大直径端的直径大于捕捞环20的心房段21直径,使得裙边部11能够完全覆盖捕捞环20的心房段21,以进一步避免在瓣环处发生的反流和可能发生的瓣周漏;在连接臂13与捕捞环20连接或抵接后,捕捞环20在轴向方向上会将人工瓣膜锚定装置10向下拉,使得裙边部11进一步紧贴瓣口,能够进一步增强防止瓣周漏的效果。In some embodiments, the skirt portion 11 includes several diamond-shaped grid support members and elastic connectors. One end of the diamond-shaped grid support member is connected to the main body 12 by an elastic connector, and the other end can be releasably connected to the corresponding delivery device during delivery; the skirt portion 11 can expand in a flower-like manner after release, and the skirt portion 11 is preferably larger than the diameter of the valve orifice to ensure complete coverage of the valve orifice, thereby preventing paravalvular leakage; in some embodiments, the diameter of the large-diameter end of the skirt portion 11 is larger than the diameter of the atrial segment 21 of the capture ring 20, so that the skirt portion 11 can completely cover the atrial segment 21 of the capture ring 20, so as to further avoid regurgitation and possible paravalvular leakage at the valve annulus; after the connecting arm 13 is connected or abutted with the capture ring 20, the capture ring 20 will pull the artificial valve anchoring device 10 downward in the axial direction, so that the skirt portion 11 is further close to the valve orifice, which can further enhance the effect of preventing paravalvular leakage.
在一些实施例中,主体部12包括一至数排多边形网格结构,相邻的网格结构间通过具有一定弹性的波杆或及节点相连,其中多边形网格优选为菱形,亦可选择五边形、六边形等可形成封闭形状的单元。In some embodiments, the main body 12 includes one to several rows of polygonal grid structures, and adjacent grid structures are connected by wave rods or nodes with a certain degree of elasticity. The polygonal grid is preferably a rhombus, and pentagons, hexagons, etc. can also be selected to form closed-shaped units.
在一些实施例中,主体部12的轴向长度过长或过短均可能会造成不良影响,一方面,若主体部12的轴向长度过长,会对流出道造成阻挡或妨碍瓣叶开合,另一方面,若主体部12的轴向长度过短,人工瓣膜30可能会相对于主体部12发生偏转,使得二者不同轴,如图9,造成密封不紧密等后果,因此主体部12的轴向长度应小于自体瓣叶的轴向长度,优选仅设置一排多边形网格,主体部12的轴向长度优选为3—8mm,既能够保证主体部12不会影响原生瓣膜组织的生理功能,又能够保证人工瓣膜30与主体部12同轴,避免人工瓣膜30发生不期望的偏转,如图8。In some embodiments, the axial length of the main body 12 may be too long or too short, which may cause adverse effects. On the one hand, if the axial length of the main body 12 is too long, it may block the outflow tract or hinder the opening and closing of the leaflets. On the other hand, if the axial length of the main body 12 is too short, the artificial valve 30 may be deflected relative to the main body 12, making the two not coaxial, as shown in Figure 9, resulting in consequences such as loose sealing. Therefore, the axial length of the main body 12 should be less than the axial length of the native leaflets. Preferably, only one row of polygonal grids is provided. The axial length of the main body 12 is preferably 3-8 mm, which can ensure that the main body 12 will not affect the physiological function of the native valve tissue, and can also ensure that the artificial valve 30 is coaxial with the main body 12, avoiding unexpected deflection of the artificial valve 30, as shown in Figure 8.
在一些实施例中,主体部12呈圆柱形结构,其外侧与捕捞环20的功能段22相适配,内侧与人工瓣膜30相适配,在主体部12的内侧中部限定有一个标准的圆形通道,此时,无论患者原生瓣环的横截面为何种不规则的形状,均能够在主体部12和捕捞环20的功能段22共同作用下被调整为标准圆形,使得人工瓣膜30能够在后续的操作过程中准确释放,稳定工作,并保证人工瓣膜30能够与瓣环的形状完全适配,避免反流。In some embodiments, the main body 12 has a cylindrical structure, the outer side of which is adapted to the functional segment 22 of the capture ring 20, and the inner side is adapted to the artificial valve 30. A standard circular channel is defined in the middle of the inner side of the main body 12. At this time, no matter what irregular shape the cross-section of the patient's native valve ring is, it can be adjusted to a standard circle under the joint action of the main body 12 and the functional segment 22 of the capture ring 20, so that the artificial valve 30 can be accurately released and work stably during subsequent operations, and ensure that the artificial valve 30 can be fully adapted to the shape of the valve ring to avoid reflux.
在一些实施例中,圆形通道的内径大于人工瓣膜30的外径,使得二者能够过盈配合,保证人工瓣膜30释放后能够稳定地与人工瓣膜锚定装置10实现连接,避免人工瓣膜30在心动周期中发生移位。更进一步地,在术中可以根据患者的流出道情况,灵活调整人工瓣膜30相对于主体部12的释放高度,以最大限度的避免流出道的阻挡,还降低了人工瓣膜30在释放时的操作难度。In some embodiments, the inner diameter of the circular channel is larger than the outer diameter of the prosthetic valve 30, allowing for an interference fit between the two. This ensures that the prosthetic valve 30 is stably connected to the prosthetic valve anchoring device 10 after release, preventing displacement of the prosthetic valve 30 during the cardiac cycle. Furthermore, during surgery, the release height of the prosthetic valve 30 relative to the main body 12 can be flexibly adjusted based on the patient's outflow tract condition to minimize outflow tract obstruction and reduce the operational difficulty of releasing the prosthetic valve 30.
在一些实施例中,当人工瓣膜锚定装置10适用于三尖瓣时,连接部优选设有三个连接臂13;当人工瓣膜锚定装置10适用于二尖瓣时,连接部优选设有两个连接臂13,多个连接臂13可呈中心对称或非对称式分布,在人工瓣膜锚定装置10释放后,连接臂13径向向外延伸,并穿入捕捞环20的功能段22的线圈间隙中,以与之连接,或者,连接臂13从功能段22的底部向外延伸,并与之相抵接,以承托整个捕捞环20。In some embodiments, when the artificial valve anchoring device 10 is suitable for the tricuspid valve, the connecting portion is preferably provided with three connecting arms 13; when the artificial valve anchoring device 10 is suitable for the mitral valve, the connecting portion is preferably provided with two connecting arms 13. The multiple connecting arms 13 can be distributed in a centrally symmetrical or asymmetrical manner. After the artificial valve anchoring device 10 is released, the connecting arms 13 extend radially outward and penetrate into the coil gap of the functional segment 22 of the capturing ring 20 to connect therewith, or, the connecting arms 13 extend outward from the bottom of the functional segment 22 and abut against it to support the entire capturing ring 20.
在一些实施例中,人工瓣膜锚定装置10适用于二尖瓣,连接部具有两个连接臂13,由于人的二尖瓣瓣叶不完全对称,因此两个连接臂13的分布位置优选与自体瓣叶40交界区域的空隙相匹配,使得连接臂13能够由自体瓣叶40交界区域的空隙中穿出,并与捕捞环20连接,此时,连接臂13的存在不会阻挡患者自体瓣叶40的开合运动,从而避免患者在手术过程中失去二尖瓣功能,发生大量反流,危及生命。In some embodiments, the artificial valve anchoring device 10 is suitable for the mitral valve, and the connecting part has two connecting arms 13. Since the human mitral valve leaflets are not completely symmetrical, the distribution positions of the two connecting arms 13 are preferably matched with the gaps in the junction area of the native leaflets 40, so that the connecting arms 13 can pass through the gaps in the junction area of the native leaflets 40 and connect to the capturing ring 20. At this time, the presence of the connecting arms 13 will not block the opening and closing movement of the patient's native leaflets 40, thereby avoiding the patient losing mitral valve function during the operation, causing a large amount of regurgitation, and endangering life.
如图6,在一些实施例中,连接臂13具有连接端131和自由端132,连接端131具有弧形倒角,且弧形倒角的圆弧内径不小于捕捞环20的线圈的横截面直径,使得连接臂13在于捕捞环20连接时,线圈能够落入该弧形倒角内,增加二者连接的稳定性;自由端132用于穿入捕捞环20的线圈间隙,且自由端132优选配置为呈圆钝结构,以防止损伤原生的瓣膜组织。As shown in Figure 6, in some embodiments, the connecting arm 13 has a connecting end 131 and a free end 132. The connecting end 131 has an arc-shaped chamfer, and the inner diameter of the arc-shaped chamfer is not less than the cross-sectional diameter of the coil of the fishing ring 20, so that when the connecting arm 13 is connected to the fishing ring 20, the coil can fall into the arc-shaped chamfer, thereby increasing the stability of the connection between the two; the free end 132 is used to penetrate the coil gap of the fishing ring 20, and the free end 132 is preferably configured as a rounded blunt structure to prevent damage to the native valve tissue.
在一些实施例中,自由端132与主体部12的夹角为α1,30°≤α1≤90°,以保证人工瓣膜锚定装置10在释放后,连接臂13能够顺利地穿入捕捞环20功能段22的相邻线圈之间,或者抵接于功能段22的底部线圈,连接臂13在径向上外露于线圈的部分能够倾斜向上延伸,避免大面积影响周围的其他组织结构。In some embodiments, the angle between the free end 132 and the main body 12 is α1, 30°≤α1≤90°, to ensure that after the artificial valve anchoring device 10 is released, the connecting arm 13 can smoothly penetrate between the adjacent coils of the functional segment 22 of the capture ring 20, or abut against the bottom coil of the functional segment 22, and the part of the connecting arm 13 radially exposed to the coil can extend upward at an angle to avoid affecting other surrounding tissue structures over a large area.
在一些实施例中,连接臂13的自由端132被配置为向外径直倾斜延伸,此时,连接臂13在释放后可以径直穿过患者自体瓣叶40交界区域的空隙,并进一步穿入相邻线圈的间隙中,或者与功能段22的底部线圈相抵接;在另外一些实施例中,连接臂13的自由端132自连接端131顺时针或逆时针偏转并向外倾斜延伸,偏转式结构能够进一步增大连接臂13与线圈之间的接触面积,以此进一步增大摩擦力,保证二者结合的紧密性。In some embodiments, the free end 132 of the connecting arm 13 is configured to extend straight outward at an angle. At this time, the connecting arm 13 can pass straight through the gap in the junction area of the patient's own valve leaflets 40 after being released, and further penetrate into the gap between adjacent coils, or abut against the bottom coil of the functional segment 22; in other embodiments, the free end 132 of the connecting arm 13 is deflected clockwise or counterclockwise from the connecting end 131 and extends outward at an angle. The deflected structure can further increase the contact area between the connecting arm 13 and the coil, thereby further increasing the friction force and ensuring the tightness of the combination of the two.
在一些实施例中,当连接臂13用于穿入捕捞环20的线圈间隙时,连接臂13的横截面厚度不小于捕捞环20功能段22相邻线圈之间的间隙,以保证连接臂13在穿入线圈间隙后与之形成稳定的过盈连接,增加二者间的摩擦力,防止二者脱离;在另外一些实施例中,连接臂13的横截面厚度小于捕捞环20功能段22相邻线圈之间的间隙,使得连接臂13更容易穿过线圈的间隙。In some embodiments, when the connecting arm 13 is used to penetrate the coil gap of the fishing ring 20, the cross-sectional thickness of the connecting arm 13 is not less than the gap between adjacent coils of the functional segment 22 of the fishing ring 20, so as to ensure that the connecting arm 13 forms a stable interference connection with the coil after penetrating the coil gap, thereby increasing the friction between the two and preventing the two from separating; in other embodiments, the cross-sectional thickness of the connecting arm 13 is less than the gap between adjacent coils of the functional segment 22 of the fishing ring 20, so that the connecting arm 13 can pass through the gap of the coil more easily.
在一些实施例中,裙边部11与主体部12通过焊接、缝合、铆接或一体成型等工艺实现连接,连接部与主体部12亦通过焊接、缝合、铆接或一体成型等工艺实现连接,三者优选使用相同的材料制成,并且在血管中输送时呈圆柱形的压缩状态,而到达心内后再通过自膨或球囊扩张打开。In some embodiments, the skirt portion 11 and the main body portion 12 are connected by welding, suturing, riveting or integral molding, and the connecting portion and the main body portion 12 are also connected by welding, suturing, riveting or integral molding. The three are preferably made of the same material and are in a cylindrical compressed state when transported in the blood vessels, and are opened by self-expansion or balloon expansion after reaching the heart.
在一些实施例中,人工瓣膜锚定装置10通过球囊实现其释放后构型的径向扩张,此时该装置整体可选择由医用不锈钢和钴铬合金等材料制作。In some embodiments, the artificial valve anchoring device 10 achieves radial expansion of its released configuration through a balloon. In this case, the entire device can be made of materials such as medical stainless steel and cobalt-chromium alloy.
在另一些实施例中,人工瓣膜锚定装置10通过自膨胀实现其释放后构型的径向扩张,此时该装置由形状记忆材料制成,优选为镍钛合金记忆材料或其他记忆高分子材料或者合金。In other embodiments, the artificial valve anchoring device 10 achieves radial expansion of its released configuration by self-expansion. In this case, the device is made of a shape memory material, preferably a nickel-titanium alloy memory material or other memory polymer materials or alloys.
在现有技术中,类似的设计方案普遍是先在手术过程中植入一个支架作为固定瓣膜的“锚定架”,然后再将人工瓣膜30置入“锚定架”当中,但在这个过程中,“锚定架”会将患者的自体瓣叶40完全撑开,使其无法正常开合,严重影响患者的心脏功能,且这种“锚定架”不能解决瓣周漏和反流的问题,必须依靠人工瓣膜30上的结构(例如瓣膜带裙边)来解决这些问题;此外,现有技术中的方案在释放人工瓣膜30时还需要考虑人工瓣膜30与“锚定架”之间的位置关系,只有人工瓣膜30放在适当位置,才能稳定的锚定,同时还需要考虑人工瓣膜30与患者瓣环的位置关系,只有瓣膜裙边紧贴瓣口,才能防止瓣周漏和反流,因此现有的方案对人工瓣膜30的释放位置要求极高,操作难度极大。In the prior art, similar design schemes generally involve first implanting a stent as an "anchoring frame" to fix the valve during surgery, and then placing the artificial valve 30 into the "anchoring frame". However, in this process, the "anchoring frame" will completely expand the patient's autologous valve leaflets 40, preventing them from opening and closing normally, seriously affecting the patient's heart function. Moreover, this "anchoring frame" cannot solve the problems of paravalvular leakage and regurgitation, and must rely on the structure on the artificial valve 30 (such as a valve skirt) to solve these problems. In addition, the schemes in the prior art also need to consider the positional relationship between the artificial valve 30 and the "anchoring frame" when releasing the artificial valve 30. Only when the artificial valve 30 is placed in the appropriate position can it be stably anchored. At the same time, the positional relationship between the artificial valve 30 and the patient's valve ring also needs to be considered. Only when the valve skirt is close to the valve orifice can paravalvular leakage and regurgitation be prevented. Therefore, the existing schemes have extremely high requirements for the release position of the artificial valve 30 and are extremely difficult to operate.
与现有技术相比,本实施例所提供的人工瓣膜锚定装置10在植入后,使得医生可以根据患者的实际情况,灵活调整人工瓣膜30的释放高度,最大限度的避免流出道阻挡;且人工瓣膜锚定装置10与捕捞环20共同作用,能够将复杂的二尖瓣结构简化为一个圆形通道,为人工瓣膜30提供稳定的锚定点,并且可以适用于绝大多数患者;由于人工瓣膜锚定装置10具有裙边部11,因此可以在人工瓣膜30释放之前即解决瓣周漏和反流的问题,并且在植入捕捞环20与人工瓣膜锚定装置10后,不会影响患者瓣叶的正常功能及运动,降低了手术风险。Compared with the prior art, the artificial valve anchoring device 10 provided in this embodiment allows the doctor to flexibly adjust the release height of the artificial valve 30 according to the actual situation of the patient after implantation, thereby avoiding outflow tract obstruction to the greatest extent; and the artificial valve anchoring device 10 and the capture ring 20 work together to simplify the complex mitral valve structure into a circular channel, providing a stable anchoring point for the artificial valve 30, and can be suitable for most patients; because the artificial valve anchoring device 10 has a skirt portion 11, it can solve the problems of paravalvular leakage and regurgitation before the artificial valve 30 is released, and after the capture ring 20 and the artificial valve anchoring device 10 are implanted, it will not affect the normal function and movement of the patient's valve leaflets, thereby reducing the surgical risk.
实施例2Example 2
本发明实施例提供了一种人工瓣膜锚定组件,包括捕捞环20及上述实施例1所述的人工瓣膜锚定装置10,已经包括于上述实施例1中的技术特征在本实施例中得到自然继承,不再一一赘述。An embodiment of the present invention provides an artificial valve anchoring assembly, including a fishing ring 20 and the artificial valve anchoring device 10 described in the above embodiment 1. The technical features already included in the above embodiment 1 are naturally inherited in this embodiment and will not be repeated one by one.
在一些实施例中,捕捞环20由内向外包括芯体及包裹层,芯体由预成形的记忆金属制成,其至少能够在径向和轴向发生弹性形变,以顺应心肌组织形状的改变,包裹层由高分子材料制成,用于提供摩擦力;进一步地,捕捞环20还设有近端连接件及显影环,近端连接件用于与递送捕捞环20的输送装置可释放连接,显影环用于观察与确定捕捞环20在手术过程中的位置。In some embodiments, the capture ring 20 includes a core and a wrapping layer from the inside to the outside. The core is made of preformed memory metal, which can undergo elastic deformation in at least the radial and axial directions to adapt to the changes in the shape of the myocardial tissue. The wrapping layer is made of a polymer material and is used to provide friction. Furthermore, the capture ring 20 is also provided with a proximal connector and a developing ring. The proximal connector is used to be releasably connected to a conveying device that delivers the capture ring 20, and the developing ring is used to observe and determine the position of the capture ring 20 during the operation.
具体地,捕捞环20的其他结构或具体规格/形状可参考现有技术所公开的任一实施方式,在本实施例中不做限定。Specifically, other structures or specific specifications/shapes of the fishing ring 20 can refer to any embodiment disclosed in the prior art and are not limited in this embodiment.
在本实施例中,以二尖瓣为例,人工瓣膜30锚定组件的植入过程具体为:首先通过经导管的方式植入捕捞环20,如图10,此时,由于捕捞环20跨过了患者的瓣口,可能导致二尖瓣出现关闭不全,并出现反流;接下来通过经导管的方式植入人工瓣膜锚定装置10,如图11,先将连接臂13对准患者自体瓣叶40交界区域的空隙,然后前后移动人工瓣膜锚定装置10,使连接臂13能够穿入并钩住捕捞环20的功能段22,然后使裙边部11覆盖住捕捞环20的心房段21,最后释放人工瓣膜锚定装置10。此时,人工瓣膜锚定装置10与捕捞环20紧密贴合,并且封堵架的裙边部11覆盖了患者的瓣环,不会出现反流或者瓣周漏等异常现象,另外,由于封堵架的主体部12高度较小,连接臂13位于患者自体瓣叶40交界区域的空隙,捕捞环20和人工瓣膜锚定装置10植入后,不会阻碍患者自身二尖瓣瓣叶的开合运动,从而避免患者在手术过程中失去二尖瓣功能,发生大量反流。In this embodiment, taking the mitral valve as an example, the implantation process of the artificial valve 30 anchoring component is specifically as follows: first, the capture ring 20 is implanted through a transcatheter method, as shown in Figure 10. At this time, since the capture ring 20 crosses the patient's valve orifice, it may cause mitral valve insufficiency and regurgitation; next, the artificial valve anchoring device 10 is implanted through a transcatheter method, as shown in Figure 11. First, the connecting arm 13 is aligned with the gap in the junction area of the patient's own valve leaflets 40, and then the artificial valve anchoring device 10 is moved back and forth so that the connecting arm 13 can penetrate and hook the functional segment 22 of the capture ring 20, and then the skirt portion 11 covers the atrial segment 21 of the capture ring 20, and finally the artificial valve anchoring device 10 is released. At this time, the artificial valve anchoring device 10 fits tightly with the capturing ring 20, and the skirt portion 11 of the occluding frame covers the patient's valve ring, so abnormal phenomena such as regurgitation or paravalvular leakage will not occur. In addition, since the main body 12 of the occluding frame is relatively small in height, the connecting arm 13 is located in the gap at the junction of the patient's own valve leaflets 40. After the capturing ring 20 and the artificial valve anchoring device 10 are implanted, they will not hinder the opening and closing movement of the patient's own mitral valve leaflets, thereby avoiding the patient from losing mitral valve function during the operation and causing a large amount of regurgitation.
实施例3Example 3
本发明实施例提供了一种经导管心脏瓣膜置换系统,如图12—图16,该系统包括人工瓣膜30及上述实施例2所述的人工瓣膜锚定组件,已经包括于上述实施例1、实施例2中的技术特征在本实施例中得到自然继承,不再一一赘述。An embodiment of the present invention provides a transcatheter heart valve replacement system, as shown in Figures 12 to 16. The system includes an artificial valve 30 and the artificial valve anchoring assembly described in the above-mentioned embodiment 2. The technical features already included in the above-mentioned embodiments 1 and 2 are naturally inherited in this embodiment and will not be repeated one by one.
在一些实施例中,人工瓣膜30在人工瓣膜锚定组件植入完成后再进行释放,且人工瓣膜30与人工瓣膜锚定装置10的主体部12过盈配合。In some embodiments, the artificial valve 30 is released after the artificial valve anchoring assembly is implanted, and the artificial valve 30 is interference fit with the main body 12 of the artificial valve anchoring device 10 .
如图13,在一些实施例中,人工瓣膜30被配置为自膨胀式瓣膜或球囊扩张式瓣膜;当被配置为自膨胀式瓣膜时,人工瓣膜30的瓣膜支架由金属或高分子材料制成,如镍钛合金记忆材料或其他记忆高分子材料或者合金,通过对上述材料进行处理,形成若干互相连接的多边形网格结构,在心内释放后可以在体温作用下自膨胀,恢复原有的性状;当被配置为球囊扩张式瓣膜时,人工瓣膜30的瓣膜支架由医用不锈钢和钴铬合金等材料制成,通过编织、焊接、铆钉连接、螺纹连接等方式预处理形成若干互相连接的多边形网格结构,在释放时,通过球囊膨胀的力量来实现人工瓣膜30的扩张,当人工瓣膜30扩张到需要的程度后,再撤出球囊。As shown in Figure 13, in some embodiments, the artificial valve 30 is configured as a self-expanding valve or a balloon-expandable valve; when configured as a self-expanding valve, the valve stent of the artificial valve 30 is made of metal or polymer materials, such as nickel-titanium alloy memory material or other memory polymer materials or alloys, and the above materials are processed to form a number of interconnected polygonal grid structures, which can self-expand under the action of body temperature and restore their original properties after being released in the heart; when configured as a balloon-expandable valve, the valve stent of the artificial valve 30 is made of medical stainless steel and cobalt-chromium alloy and other materials, and is pre-processed by weaving, welding, riveting, threading, etc. to form a number of interconnected polygonal grid structures, and when released, the expansion of the artificial valve 30 is achieved by the force of the balloon expansion, and when the artificial valve 30 expands to the required extent, the balloon is withdrawn.
在本实施例中,人工瓣膜30的具体结构及操作方式可选择现有技术所公开的任一实施方式,在此不再具体限定及赘述。In this embodiment, the specific structure and operation mode of the artificial valve 30 can be selected from any embodiment disclosed in the prior art, and will not be specifically limited or elaborated herein.
在本实施例中,以二尖瓣和球囊扩张式瓣膜为例,经导管心脏瓣膜置换系统的操作过程具体为:首先依次释放捕捞环20及人工瓣膜锚定装置10,具体操作过程见上述实施例2,然后通过经导管的方式植入人工瓣膜30,人工瓣膜30在人工瓣膜锚定装置10的内部展开,如图12,由于人工瓣膜30的外径大于人工瓣膜锚定装置10的主体部12内径,二者能够实现过盈配合,使得人工瓣膜30能够稳定地锚定于人工瓣膜锚定装置10内部,还可以根据患者的流出道情况,调整人工瓣膜30的释放高度,如图15及图16,以最大限度的避免流出道阻挡,此时,人工瓣膜30与人工瓣膜锚定装置10紧密贴合,在裙边部11的作用下,人工瓣膜30无瓣周漏及反流的现象发生。In this embodiment, taking the mitral valve and balloon-expandable valve as examples, the operation process of the transcatheter heart valve replacement system is specifically as follows: first, the capture ring 20 and the artificial valve anchoring device 10 are released in sequence, and the specific operation process is shown in the above-mentioned embodiment 2. Then, the artificial valve 30 is implanted through a transcatheter method, and the artificial valve 30 is unfolded inside the artificial valve anchoring device 10, as shown in Figure 12. Since the outer diameter of the artificial valve 30 is larger than the inner diameter of the main body 12 of the artificial valve anchoring device 10, the two can achieve an interference fit, so that the artificial valve 30 can be stably anchored inside the artificial valve anchoring device 10. The release height of the artificial valve 30 can also be adjusted according to the patient's outflow tract condition, as shown in Figures 15 and 16, to minimize outflow tract obstruction. At this time, the artificial valve 30 is tightly fitted with the artificial valve anchoring device 10. Under the action of the skirt 11, the artificial valve 30 has no paravalvular leakage or regurgitation.
相较于现有技术,本实施例中的捕捞环20与人工瓣膜锚定装置10分两次植入,能够有效减小输送装置的profile值,降低输送难度,减小对患者血管的伤害;人工瓣膜30选择球囊扩张式瓣膜,相较于带裙边的自膨胀式瓣膜,输送系统更为简单,profile值更小,释放位置的准确度要求低,操作难度更低;相较于带瓣叶的自膨胀式瓣膜,植入人工瓣膜锚定装置10的难度更低,人工瓣膜锚定装置10的长度更短,输送系统的profile值更小,输送系统的结构更简单。Compared with the existing technology, the capture ring 20 and the artificial valve anchoring device 10 in this embodiment are implanted twice, which can effectively reduce the profile value of the delivery device, reduce the difficulty of delivery, and reduce damage to the patient's blood vessels; the artificial valve 30 selects a balloon-expandable valve. Compared with the self-expanding valve with a skirt, the delivery system is simpler, the profile value is smaller, the accuracy requirement of the release position is low, and the operation difficulty is lower; compared with the self-expanding valve with leaflets, the difficulty of implanting the artificial valve anchoring device 10 is lower, the length of the artificial valve anchoring device 10 is shorter, the profile value of the delivery system is smaller, and the structure of the delivery system is simpler.
上面结合附图对本发明的实施例进行了描述,但是本发明并不局限于上述的具体实施方式,上述的具体实施方式仅仅是示意性的,而不是限制性的,本领域的普通技术人员在本发明的启示下,在不脱离本发明宗旨和权利要求所保护的范围情况下,还可做出很多形式,均属于本发明的保护之内。The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementation methods. The above-mentioned specific implementation methods are merely illustrative and not restrictive. Under the guidance of the present invention, ordinary technicians in this field can also make many forms without departing from the scope of protection of the present invention and the claims, all of which are protected by the present invention.
Claims (14)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410429447.4A CN118356276A (en) | 2024-04-10 | 2024-04-10 | Prosthetic valve anchoring device, assembly and transcatheter heart valve replacement system |
| CN202410429447.4 | 2024-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025214074A1 true WO2025214074A1 (en) | 2025-10-16 |
Family
ID=91875867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2025/082623 Pending WO2025214074A1 (en) | 2024-04-10 | 2025-03-14 | Artificial valve anchoring device and assembly, and transcatheter heart valve replacement system |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN118356276A (en) |
| WO (1) | WO2025214074A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118356276A (en) * | 2024-04-10 | 2024-07-19 | 上海纽脉医疗科技股份有限公司 | Prosthetic valve anchoring device, assembly and transcatheter heart valve replacement system |
| CN120036992A (en) * | 2025-01-23 | 2025-05-27 | 上海纽脉医疗科技股份有限公司 | Transcatheter heart valve repair assembly and system |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112716658A (en) * | 2021-01-20 | 2021-04-30 | 上海捍宇医疗科技股份有限公司 | Transcatheter atrioventricular valve replacement system |
| US20220054261A1 (en) * | 2019-04-12 | 2022-02-24 | Shifamed Holdings, Llc | Minimal frame prosthetic cardiac valve delivery devices, systems, and methods |
| CN115381603A (en) * | 2021-09-30 | 2022-11-25 | 宁波健世科技股份有限公司 | A Heart Valve Prosthesis Anchorable to Native Valve Leaflets |
| CN115486972A (en) * | 2021-09-30 | 2022-12-20 | 宁波健世科技股份有限公司 | A Displacement System Avoiding Outflow Tract Obstruction |
| CN115607338A (en) * | 2022-10-21 | 2023-01-17 | 上海纽脉医疗科技股份有限公司 | Transcatheter heart valve replacement system |
| WO2023246278A1 (en) * | 2022-06-24 | 2023-12-28 | 上海纽脉医疗科技股份有限公司 | Artificial heart valve |
| CN118356276A (en) * | 2024-04-10 | 2024-07-19 | 上海纽脉医疗科技股份有限公司 | Prosthetic valve anchoring device, assembly and transcatheter heart valve replacement system |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10117744B2 (en) * | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
| EP4434495A4 (en) * | 2021-11-17 | 2025-10-29 | Beijing Balance Medical Tech Co Ltd | SPLIT PRECISELY ANCHORED INTERVENTIONAL VALVE-IN-RING SYSTEM |
-
2024
- 2024-04-10 CN CN202410429447.4A patent/CN118356276A/en active Pending
-
2025
- 2025-03-14 WO PCT/CN2025/082623 patent/WO2025214074A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220054261A1 (en) * | 2019-04-12 | 2022-02-24 | Shifamed Holdings, Llc | Minimal frame prosthetic cardiac valve delivery devices, systems, and methods |
| CN112716658A (en) * | 2021-01-20 | 2021-04-30 | 上海捍宇医疗科技股份有限公司 | Transcatheter atrioventricular valve replacement system |
| CN115381603A (en) * | 2021-09-30 | 2022-11-25 | 宁波健世科技股份有限公司 | A Heart Valve Prosthesis Anchorable to Native Valve Leaflets |
| CN115486972A (en) * | 2021-09-30 | 2022-12-20 | 宁波健世科技股份有限公司 | A Displacement System Avoiding Outflow Tract Obstruction |
| WO2023246278A1 (en) * | 2022-06-24 | 2023-12-28 | 上海纽脉医疗科技股份有限公司 | Artificial heart valve |
| CN115607338A (en) * | 2022-10-21 | 2023-01-17 | 上海纽脉医疗科技股份有限公司 | Transcatheter heart valve replacement system |
| CN118356276A (en) * | 2024-04-10 | 2024-07-19 | 上海纽脉医疗科技股份有限公司 | Prosthetic valve anchoring device, assembly and transcatheter heart valve replacement system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118356276A (en) | 2024-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12478473B2 (en) | Valve prosthesis and method for delivery | |
| US10869757B2 (en) | Valve prosthesis and method for delivery | |
| US9937035B2 (en) | Valve prosthesis | |
| CN112336498B (en) | Mitral valve assembly | |
| AU2009240565B2 (en) | Stented heart valve devices | |
| CN102985032B (en) | mitral valve prosthesis | |
| EP3760165A1 (en) | Stented heart valve devices | |
| WO2025214074A1 (en) | Artificial valve anchoring device and assembly, and transcatheter heart valve replacement system | |
| CN220069928U (en) | Implantable prosthetic devices | |
| CN219354275U (en) | Valve repair device and system | |
| HK40045359A (en) | Mitral valve assembly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 25785554 Country of ref document: EP Kind code of ref document: A1 |